InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the full record of transactions filed by Pauling David. Director active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 3 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €9k. History available since 15 October 2025. The latest transaction was filed on 4 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations